Moreover, the downregulation of E3 ubiquitin ligases (Parkin and RNF5), or upregulation of deubiquitinating enzyme JOSD2, has been reported as crucial mechanism for PHGDH overexpression in breast cancer or lung adenocarcinoma26–28. The gene discussed is PRKN; the disease is breast carcinoma.